These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20541584)

  • 1. Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?
    Double KL; Reyes S; Werry EL; Halliday GM
    Prog Neurobiol; 2010 Nov; 92(3):316-29. PubMed ID: 20541584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential vulnerabilities of substantia nigra catecholamine neurons to excitatory amino acid-induced degeneration in rat midbrain slices.
    Bywood PT; Johnson SM
    Exp Neurol; 2000 Mar; 162(1):180-8. PubMed ID: 10716898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal vulnerability in Parkinson's disease.
    Double KL
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S52-4. PubMed ID: 22166454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aging, disease and nerve cell death].
    Agid Y
    Bull Acad Natl Med; 1995 Jun; 179(6):1193-203; discussion 1203-7. PubMed ID: 8542348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
    Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
    J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
    Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
    Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
    Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
    J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of nigral cell death in Parkinson's disease.
    Przedborski S
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W; Zhang Z; Gash DM; Mattson MP
    Ann Neurol; 1999 Oct; 46(4):587-97. PubMed ID: 10514095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
    Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
    Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders.
    Goemaere J; Knoops B
    J Comp Neurol; 2012 Feb; 520(2):258-80. PubMed ID: 21674491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system.
    Vernier P; Moret F; Callier S; Snapyan M; Wersinger C; Sidhu A
    Ann N Y Acad Sci; 2004 Dec; 1035():231-49. PubMed ID: 15681811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.
    Sedaghat K; Finkelstein DI; Gundlach AL
    Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.